Komori
CellSource (4880) · InitiativeAdvanced

Governance by the Board of Directors, Board of Corporate Auditors, Management Committee and Risk Council

First written in FY2019. 5 of 7 entries say "Advanced", first in FY2021. Latest entry: 2026-04-23.

7entries
7years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019 – FY2020AdvancedFY2021 – 2026-04-232020: 120202021: 120212022: 120222023: 220232024: 020242025: 020252026: 22026
Same theme, other companies

23 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 70 companies compared. The sentences above are computed from all 70.
Full recordFilings, disclosures and news, newest first
  1. 2026-04-23AdvancedM&A and Subsidiary Changes

    「Through this merger, we will integrate the expertise cultivated by ハイブリッドメディカル社 with our management resources, thereby improving operating efficiency across the group and strengthening our governance structure.」

    A specific organizational restructuring was decided upon to strengthen operating efficiency and the governance structure across the group through the absorption-type merger of the wholly owned subsidiary.
  2. FY2025AdvancedAnnual report

    「As of the filing date, the Board of Directors comprises 5 members, consisting of the Representative Director, President and CEO as chair, 2 directors excluding directors serving as Audit and Supervisory Committee members, and 3 directors serving as Audit and Supervisory Committee members, including 2 outside directors.」

    The company continues to operate as a company with an Audit and Supervisory Committee. As of the filing date, the Board of Directors comprises 5 members, including 2 outside directors and 3 Audit and Supervisory Committee members. The delegation of authority to the Executive Committee and monthly meetings of the Compliance and Risk Council have also been specified.
  3. FY2023-Q3AdvancedAnnual report

    「The company considers business-related laws and regulations, risk response and other matters at its internal Compliance and Risk Council, which meets regularly every other month. By maintaining and strengthening its internal management systems, it has established a management foundation that ensures the maintenance of permits and registrations required under these laws and regulations and thorough compliance with laws, regulations and related rules.」

    The Compliance and Risk Council meets regularly every other month to consider laws and regulations, risk response, and the maintenance of permits and registrations and compliance with laws and regulations.
  4. FY2022AdvancedAnnual report

    「In January 2023, the company transitioned to a company with an Audit and Supervisory Committee in order to further strengthen the management and supervisory functions of the Board of Directors, which makes important management decisions and supervises business execution, and to further improve the agility and efficiency of business execution.」

    The governance structure was specifically expanded through the transition to a company with an Audit and Supervisory Committee, the establishment of a Nomination and Compensation Advisory Committee and HSF Management Promotion Council, and a 7-member structure including 4 outside directors.
  5. FY2021AdvancedAnnual report

    「As of the filing date, the Board of Directors comprises 6 directors, including 3 outside directors. As the decision-making body for the management of the company, it decides matters prescribed by laws and regulations and the Articles of Incorporation, as well as basic management policies and important matters, and supervises the execution of duties by the directors.」

    The Board of Directors comprises 6 members, including 3 outside directors, and all 3 corporate auditors are outside corporate auditors. The specific composition of the governance structure, including the Executive Committee and Compliance and Risk Council, was also disclosed.
  6. FY2020RestatedAnnual report

    「The company is a company with a Board of Corporate Auditors and has established a Board of Directors and a Board of Corporate Auditors. It has also established an Executive Committee and a Compliance and Risk Council to complement the functions of the Board of Directors and the Board of Corporate Auditors.」

    The governance structure comprising the Board of Directors, Board of Corporate Auditors, Executive Committee and Compliance and Risk Council continues.
  7. FY2019First statedAnnual report

    「The company is a company with a Board of Corporate Auditors and has established a Board of Directors and a Board of Corporate Auditors. It has also established an Executive Committee and a Compliance and Risk Council to complement the functions of the Board of Directors and the Board of Corporate Auditors.」

    The company has adopted a governance structure combining the Board of Directors, outside corporate auditors, Executive Committee and Compliance and Risk Council.
Moved together

"Increase in Partner Medical Institutions and Expansion into New Treatment Areas" moved the same way as this thread, in the same document, in 4 of its 7 moves.

433333★123456
  1. ★This thread
  2. 1Increase in Partner Medical Institutions and Expansion into New Treatment Areas4×
  3. 2Improving contract processing capacity3×
  4. 3Revenue and Profit Growth Since Founding and Expansion of the Regenerative Medicine-Related Business3×
  5. 4Executive Compensation Design Linked to Performance and Focused on Enhancing Corporate Value3×
  6. 5Investment in Human Capital and Strengthening Recruitment and Development3×
  7. 6Strengthening Internal Control, Internal Management and Information Management Systems3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for CellSource yet. It last moved in the M&A and Subsidiary Changes of 2026-04-23: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Governance by the Board of Directors, Board of Corporate Auditors, Management Committee and Risk Council | CellSource Co.,Ltd. (4880) | Komori